PATENT CLAIM ANALYSIS

Application Number: 16040356
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["424", "093400"]

Abstract:
The invention provides compositions comprising bacterial strains for treating and preventing inflammatory and autoimmune diseases.

Claim (Index 55):
The method of  claim 51 , wherein the disorder mediated by the Th17 pathway is selected from the group consisting of: uveitis, multiple sclerosis, arthritis, neuromyelitis optica, psoriasis, systemic lupus erythematosus, an inflammatory bowel disease, celiac disease, asthma, chronic obstructive pulmonary disease (COPD), scleritis, vasculitis, Behcet's disease, atherosclerosis, atopic dermatitis, emphysema, periodontitis, allergic rhinitis, and allograft rejection.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 95.0
- Lexical Diversity: 1.06667
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15592178', '15679857', '15842635', '15673270', '15359988']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8133228688553192
- 35 USC 102 Novelty (BERT): 0.6889350330810332
- Combined Prediction Score: 0.8008840852778906
- Mean Citation Score: 642.1029860000001
- Max Citation Score: 808.00085
- Similarity Product: 673.0231970772236

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test